I am Professor of Molecular Medicine at Anglia Ruskin University in the United Kingdom. I work full-time in the laboratory, improving conventional qPCR and dPCR protocols and developing ultrafast amplification methods for point-of-care diagnostics. My research centres on innovative assay design, extreme amplification strategies and their translation into reliable molecular diagnostics. I also led the development of the internationally adopted MIQE guidelines, which have improved the quality, reliability and reproducibility of PCR-based research and diagnostics worldwide.

My expertise is sought by governments, industry, healthcare organisations and the legal profession, where I provide independent advice on molecular diagnostics, assay development and PCR methodology. As an expert witness, I have provided independent scientific evidence in complex legal cases involving PCR and molecular evidence. My work has influenced international standards and best practice, contributing to the accurate interpretation and application of nucleic acid technologies in research, healthcare and legal proceedings.